Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
Lindenfeld J, Zile MR, Desai AS, Bhatt K, Ducharme A, Horstmanshof D, Krim SR, Maisel A, Mehra MR, Paul S, Sears SF, Sauer AJ, Smart F, Zughaib M, Castaneda P, Kelly J, Johnson N, Sood P, Ginn G, Henderson J, Adamson PB, Costanzo MR.
Lancet. 2021 Sep 11;398(10304):991-1001. doi: 10.1016/S0140-6736(21)01754-2. Epub 2021 Aug 27.
PMID:34461042
Body composition changes assessed by bioelectrical impedance and their associations with functional class deterioration in stable heart failure patients.
Castillo-Martínez L, Santillan-Díaz C, Orea-Tejeda A, Gómez-Martínez MA, Bernal-Ceballos F, Lozada-Mellado M.
Nutr Hosp. 2016 Jun 30;33(3):270. doi: 10.20960/nh.270.
PMID:27513497
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.
Greene SJ, Butler J, Spertus JA, Hellkamp AS, Vaduganathan M, DeVore AD, Albert NM, Duffy CI, Patterson JH, Thomas L, Williams FB, Hernandez AF, Fonarow GC.
JAMA Cardiol. 2021 May 1;6(5):522-531. doi: 10.1001/jamacardio.2021.0372.
PMID:33760037
New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome.
Bredy C, Ministeri M, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Diller GP, Gatzoulis MA, Dimopoulos K.
Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):51-58. doi: 10.1093/ehjqcco/qcx031.
PMID:28950356
The effect of inspiratory muscle training on fatigue and dyspnea in patients with heart failure: A randomized, controlled trial.